전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyLimited DatastaleAstraZenecaPhase 3

durvalumab (Imfinzi, MEDI4736, MEDI4736 (Durvalumab) + Tremelimumab)

Non-Small-Cell Lung Carcinoma NSCLC · Advanced Solid Malignancies

#AdvancedSolidMalignancies#Antibody#Phase3#Popular#monoclonal-antibody+2
Trials 56Status Recruiting
ADCLimited DatastaleMerck Sharp & Dohme LLCPhase 1

sacituzumab govitecan (Trodelvy, Sacituzumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#Popular#antibody-drug-conjugate+2
Trials 56Status Active
ADCStandard DatabasestaleDaiichi SankyoDM1) and trastuzumab deruxt…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzmab deruxtecan)

Gastric Cancer; Gastroesophageal Junction (GEJ) Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 56Status Recruiting
CGTLimited DatastaleCarbiogene Therapeutics Co. Ltd.Phase 2

anti-BCMA CAR-T (anti-BCMA CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
CGTStandard DatabasestaleNational Cancer Institute (NCI)Phase 2

Anti-cluster of differentiation 19 (CD19, Anti-cluster of differentiation 19, Anti-cluster of differentiation 19 (CD19)-CAR PBL)

Primary Mediastinal B-cell Lymphoma; Diffuse, Large B-cell Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 55Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Anti-cluster of differentiation 19 (CD19, Anti-cluster of differentiation 19, Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptor (CAR) T cells)

Lymphoma, B-Cell; Lymphoma, Non-hodgkins · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 55Status Active
CGTLimited DatastaleTakara Bio Inc.Phase 1

TS-1 (TS-1)

Pancreatic Cancer Stage III; Pancreatic Cancer Stage IV · Pancreatic Cancer Stage III

#PancreaticCancerStageIII#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 55Status Recruiting
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Androgen receptor inhibitor (Androgen receptor inhibitor)

Prostate Cancer · Prostate Cancer

#ProstateCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 54Status Recruiting
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD19/CD22 CAR T-Cells (CD19/CD22 CAR T-Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
CGTLimited DatastaleShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 54Status Active
AntibodyCurated CorestalePfizerApproved

Elranatamab (Elranatamab)

Multiple Myeloma · FRα

#FR#Antibody#Approved#BioJungboMoa-pick#Popular+4
Trials 54Status Recruiting
AntibodyCurated CorestaleGSKApproved

Mepolizumab (Mepolizumab)

Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic · Asthma

#Asthma#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 54Status Active
CGTLimited DatastaleInternational Brain Research Fo…Phase 2

Quercetin (Quercetin)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
AntibodyLimited DatastaleJiangsu Hansoh Pharmaceutical C…Phase 2

adebrelimab and chemotherapy (adebrelimab and chemotherapy)

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer · Efficacy and Safety of Neoadjuvant Immun

#EfficacyandSafetyofNeoadjuvantIm#Antibody#Phase2#Popular#monoclonal-antibody+1
Trials 54Status Recruiting
CGTLimited DatastaleJohnson & Johnson Pharmaceutica…Approved

intralipid (intralipid)

Pregnancy Complicated by Low Implantation · Pregnancy Complicated by Low Implantatio

#PregnancyComplicatedbyLowImplant#CGT#Approved#Popular#cell-gene-therapy+4
Trials 54Status Discontinued
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab - 28 Day Cycle)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 53Status Recruiting
CGTStandard DatabasestaleKiteApproved

axicabtagene ciloleucel (Yescarta, axi-cel)

DLBCL; Diffuse Large B Cell Lymphoma · FRα

#FR#CGT#Approved#Popular#cell-gene-therapy+5
Trials 53Status Recruiting
AntibodyLimited DatastaleAstraZenecaPreclinical

Benralizumab (Benralizumab)

Asthma · Asthma

#Asthma#Antibody#Preclinical#Popular#monoclonal-antibody+2
Trials 53Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Preclinical

CD19+CD22 CAR-T (CD19+CD22 CAR-T)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#Popular#cell-gene-therapy+5
Trials 53Status Active
CGTLimited DatastaleCRISPR Therapeutics AGPhase 1

CD19-directed CAR-T cells (CD19-directed CAR-T cells)

B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 53Status Active

10 / 103 pages

← PreviousNext →